• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有替诺福韦的脂质体的配方和传输特性通过 Caco-2 细胞模型。

Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model.

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University , Jeddah , KSA .

出版信息

J Liposome Res. 2013 Dec;23(4):318-26. doi: 10.3109/08982104.2013.810645. Epub 2013 Aug 5.

DOI:10.3109/08982104.2013.810645
PMID:23915251
Abstract

The aim was to investigate the potential of proliposomes to improve the permeability of tenofovir, anti-HIV, for oral delivery. Tenofovir was incorporated into phosphatidylcholine proliposomes and their absorption was determined in Caco-2 cell cultures grown on Transwell inserts using aqueous drug solutions as reference. Five batches of proliposomes were prepared with different stearylamine levels and characterized in terms of vesicular morphology, drug encapsulation efficiency (EEF), drug leakage, vesicular sizing and surface charges. Cytotoxicity of the reconstituted liposomes was evaluated by the MTT assay. The obtained results showed that increasing the incorporated percentage of stearylamine led to an increase in drug encapsulation, a slower drug leakage and larger liposomes formed. Compared to the drug solutions at corresponding concentrations, the proposed formulations showed a positive relationship (R²= 0.9756) for the influence of increasing the stearylamine percentage on reduction of mitochondrial activity. Regarding the drug permeability, enhancements of apparent permeability by 16.5- and 5.2-folds were observed for proliposomes formulations with 5% and 15% stearylamine, respectively. A good correlation was observed between the Caco-2 and dialysis models that might indicate passive diffusion as well as paracellular transport as suggested mechanisms for drug absorption. Cationic proliposomes offered a potential formulation to improve the permeation of tenofovir.

摘要

目的在于研究前体脂质体提高抗 HIV 药物替诺福韦经口服递送的通透性的潜力。将替诺福韦纳入磷脂酰胆碱前体脂质体中,并使用水性药物溶液作为参考,在 Transwell 插入物上生长的 Caco-2 细胞培养物中测定其吸收情况。用不同硬脂胺水平制备了五批前体脂质体,并根据囊泡形态、药物包封效率(EEF)、药物泄漏、囊泡粒径和表面电荷对其进行了表征。通过 MTT 测定法评估了再构成的脂质体的细胞毒性。结果表明,增加硬脂胺的掺入百分比会导致药物包封增加、药物泄漏减慢和形成更大的囊泡。与相应浓度的药物溶液相比,对于增加硬脂胺百分比对降低线粒体活性的影响,所提出的制剂表现出正相关关系(R²=0.9756)。关于药物通透性,含有 5%和 15%硬脂胺的前体脂质体制剂的表观通透性分别增强了 16.5 倍和 5.2 倍。在 Caco-2 和透析模型之间观察到良好的相关性,这可能表明药物吸收的机制是被动扩散和细胞旁转运。阳离子前体脂质体为提高替诺福韦的通透性提供了一种潜在的制剂。

相似文献

1
Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model.载有替诺福韦的脂质体的配方和传输特性通过 Caco-2 细胞模型。
J Liposome Res. 2013 Dec;23(4):318-26. doi: 10.3109/08982104.2013.810645. Epub 2013 Aug 5.
2
Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.在Caco-2细胞模型中,使用磷脂作为增溶剂对受顶端外排影响的难溶性药物进行吸收研究。
Eur J Pharm Biopharm. 2007 Apr;66(1):146-58. doi: 10.1016/j.ejpb.2006.08.010. Epub 2006 Aug 23.
3
Near-infrared investigations of novel anti-HIV tenofovir liposomes.新型抗 HIV 替诺福韦脂质体的近红外研究。
AAPS J. 2010 Jun;12(2):202-14. doi: 10.1208/s12248-010-9177-1. Epub 2010 Mar 3.
4
Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers.TMC114/利托那韦与替诺福韦酯在健康志愿者中的药代动力学相互作用。
Br J Clin Pharmacol. 2007 Nov;64(5):655-61. doi: 10.1111/j.1365-2125.2007.02957.x. Epub 2007 Jul 4.
5
Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.负载抗艾滋病药物的囊泡凝胶的粘膜粘附性和皮肤渗透性最大化。
J Pharm Sci. 2014 Mar;103(3):952-64. doi: 10.1002/jps.23867. Epub 2014 Jan 24.
6
Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing.阿利克仑富马酸盐前体脂质体改善口服药物递送:制剂开发、体外和体内渗透测试。
Molecules. 2022 Jul 28;27(15):4828. doi: 10.3390/molecules27154828.
7
Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.用于改善口服给药的依西美坦前体脂质体:使用平行人工膜渗透测定法、人结肠腺癌细胞系Caco-2和大鼠肠道进行的制剂配方及体外评价
Int J Pharm. 2009 Oct 1;380(1-2):96-104. doi: 10.1016/j.ijpharm.2009.07.008. Epub 2009 Jul 17.
8
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.从含有胆盐的前体脂质体中增强鲑鱼降钙素(sCT)的肠道吸收。
J Control Release. 2005 Sep 2;106(3):298-308. doi: 10.1016/j.jconrel.2005.05.016.
9
Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.盐酸多奈哌齐载入前体脂质体的配方:使用 Caco-2 和大鼠模型的体外和体内评估。
AAPS PharmSciTech. 2019 Jun 18;20(6):226. doi: 10.1208/s12249-019-1437-5.
10
Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).脂质体制剂对卡巴拉汀透过人结肠腺癌细胞系(CACO-2)转运影响的研究。
Pharmazie. 2010 Jan;65(1):32-40.

引用本文的文献

1
Molecularly Imprinted Polymeric Nanoparticles as Drug Delivery System for Tenofovir, an Acyclic Nucleoside Phosphonate Antiviral.分子印迹聚合物纳米颗粒作为替诺福韦(一种无环核苷膦酸抗病毒药物)的药物递送系统
Pharmaceutics. 2024 Jul 21;16(7):965. doi: 10.3390/pharmaceutics16070965.
2
Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics.用于5-氟尿嘧啶和紫杉醇作为化疗药物的可控共递送的脂质体-胶束杂化(LMH)载体
Pharmaceutics. 2023 Jul 4;15(7):1886. doi: 10.3390/pharmaceutics15071886.
3
Proliposome-Based Nanostrategies: Challenges and Development as Drug Delivery Systems.
基于前体脂质体的纳米策略:作为药物传递系统的挑战与发展。
AAPS PharmSciTech. 2022 Nov 3;23(8):293. doi: 10.1208/s12249-022-02443-1.
4
Liposome-polymer complex for drug delivery system and vaccine stabilization.用于药物递送系统和疫苗稳定化的脂质体-聚合物复合物
Heliyon. 2022 Feb 12;8(2):e08934. doi: 10.1016/j.heliyon.2022.e08934. eCollection 2022 Feb.
5
Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances.用于抗HIV治疗的脂质纳米载体:聚焦物理化学性质与生物技术进展
Pharmaceutics. 2021 Aug 19;13(8):1294. doi: 10.3390/pharmaceutics13081294.
6
Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: The role of stereology.纳米颗粒递药系统、高效抗逆转录病毒治疗和睾丸形态学:体视学的作用。
Pharmacol Res Perspect. 2021 May;9(3):e00776. doi: 10.1002/prp2.776.
7
Spontaneous In Situ Formation of Liposomes from Inert Porous Microparticles for Oral Drug Delivery.用于口服给药的惰性多孔微粒自发原位形成脂质体
Pharmaceutics. 2020 Aug 15;12(8):777. doi: 10.3390/pharmaceutics12080777.
8
Design of bile-based vesicles (BBVs) for hepatocytes specific delivery of Daclatasvir: Comparison of ex-vivo transenterocytic transport, in-vitro protein adsorption resistance and HepG2 cellular uptake of charged and β-sitosterol decorated vesicles.基于胆汁的囊泡(BBVs)的设计用于实现达卡他韦对肝细胞的特异性递送:比较带电荷和β-谷甾醇修饰囊泡的体外跨肠细胞转运、体外蛋白吸附抗性和 HepG2 细胞摄取。
PLoS One. 2019 Jul 16;14(7):e0219752. doi: 10.1371/journal.pone.0219752. eCollection 2019.
9
The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: and Models.临床前药代动力学和药效学工具箱:以及模型。
Front Pharmacol. 2019 May 24;10:578. doi: 10.3389/fphar.2019.00578. eCollection 2019.
10
Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.用于盐酸小檗碱口服淋巴靶向的生物活性乳糜微粒:基于组织和 Caco-2 细胞系模型的新型流量阻断分析方法。
Pharm Res. 2018 Jan 5;35(1):18. doi: 10.1007/s11095-017-2307-z.